X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs MYLAN (US) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   MYLAN
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
MYLAN
Dec-14
LUPIN LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,7503,805-   
Low Rs1,3842,682-   
Sales per share (Unadj.) Rs387.41,302.8-  
Earnings per share (Unadj.) Rs56.6156.9-  
Cash flow per share (Unadj.) Rs76.8252.6-  
Dividends per share (Unadj.) Rs7.500-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs298.9647.6-  
Shares outstanding (eoy) m451.58378.37-   
Bonus/Rights/Conversions ESOPSOI-  
Price / Sales ratio x4.02.5 162.4%   
Avg P/E ratio x27.720.7 133.9%  
P/CF ratio (eoy) x20.412.8 158.8%  
Price / Book Value ratio x5.25.0 104.7%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m707,5131,227,273 57.6%   
No. of employees `00016.825.0 67.2%   
Total wages/salary Rs m28,4950-   
Avg. sales/employee Rs Th10,418.319,716.9 52.8%   
Avg. wages/employee Rs Th1,697.00-   
Avg. net profit/employee Rs Th1,523.02,375.2 64.1%   
INCOME DATA
Net Sales Rs m174,943492,922 35.5%  
Other income Rs m1,065-2,873 -37.1%   
Total revenues Rs m176,008490,049 35.9%   
Gross profit Rs m44,931122,592 36.7%  
Depreciation Rs m9,12236,203 25.2%   
Interest Rs m1,52521,262 7.2%   
Profit before tax Rs m35,34962,254 56.8%   
Minority Interest Rs m-72-255 28.1%   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,7852,618 373.8%   
Profit after tax Rs m25,57559,381 43.1%  
Gross profit margin %25.724.9 103.3%  
Effective tax rate %27.74.2 658.3%   
Net profit margin %14.612.0 121.4%  
BALANCE SHEET DATA
Current assets Rs m119,542433,344 27.6%   
Current liabilities Rs m61,206338,788 18.1%   
Net working cap to sales %33.319.2 173.8%  
Current ratio x2.01.3 152.7%  
Inventory Days Days7678 97.4%  
Debtors Days Days90107 83.8%  
Net fixed assets Rs m131,660114,036 115.5%   
Share capital Rs m90317,431 5.2%   
"Free" reserves Rs m134,0730-   
Net worth Rs m134,976245,031 55.1%   
Long term debt Rs m56,478366,052 15.4%   
Total assets Rs m266,073986,961 27.0%  
Interest coverage x24.23.9 615.5%   
Debt to equity ratio x0.41.5 28.0%  
Sales to assets ratio x0.70.5 131.6%   
Return on assets %10.28.2 124.7%  
Return on equity %18.924.2 78.2%  
Return on capital %19.313.6 141.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m60,3780-   
CASH FLOW
From Operations Rs m41,14864,795 63.5%  
From Investments Rs m-25,287-51,099 49.5%  
From Financial Activity Rs m4,332-17,073 -25.4%  
Net Cashflow Rs m20,193-3,378 -597.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare LUPIN LTD With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare LUPIN LTD With: FDC LTD.  BIOCON LTD  WYETH LTD  DISHMAN PHARMA  IPCA LABS  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views On News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - WYETH LTD COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS